Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
13.12
+0.13 (1.00%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $493.59 million as of October 2, 2026. Its market cap has increased by 59.87% in one year.
Market Cap
493.59M
Enterprise Value
263.61M
1-Year Change
59.87%
Ranking
Category
Stock Price
$13.12
ChartMarket Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $493.59M, an increase of 22.76%. That is a compound annual growth rate of 8.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 493.59M | 18.22% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Monopar Therapeutics | 534.76M |
| YD Bio | 525.57M |
| Autolus Therapeutics | 516.36M |
| Puma Biotechnology | 512.59M |
| Arvinas | 505.76M |
| Entera Bio | 503.84M |
| ProKidney | 501.86M |
| REGENXBIO | 497.08M |